Drug profile · INN
ergocalciferol
ERGOCALCIFEROL
ergocalciferol (ERGOCALCIFEROL) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — ergocalciferol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 33
- Data quality
- 0.84
Quick answer
ergocalciferol (ERGOCALCIFEROL) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin D receptor agonist
Primary target: Vitamin D3 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12358976
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
granted -
US 12214021
Study on lactoferrin regulation of bone formation by means of vitamin D receptor
granted -
US 12202822
Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition
granted -
US 12018255
Compositions and methods for treating disorders of genomic imprinting
granted -
US 11952419
Reagents and methods for treating cancer and autoimmune disease
granted -
US 11903952
Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection
granted -
US 11833254
Discoidal nano universal platform for efficient delivery of PNAs
granted -
US 11512078
Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition
granted -
US 11497197
Methods for enhancing poultry growth and performance
granted -
US 11479617
Chelator-functionalized glycosaminoglycans
granted -
US 11390613
Azole analogues and methods of use thereof
granted -
US 11364309
Neuronal enhancers
granted -
US 11103523
Self-assembled brush block copolymer-nanoparticles for drug delivery
granted -
US 11008378
Compositions and methods for immunomodulation in an organism
granted -
US 10814006
Fluorescent prodrugs
granted -
US 10464993
Compositions and methods for immunomodulation in an organism
granted -
US 10344040
Pyridone and aza-pyridone compounds and methods of use
granted -
US 10280158
Immune adjustment compound, use thereof and pharmaceutical composition comprising same
granted -
US 10258635
Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases
granted -
US 10053469
Pyridone and aza-pyridone compounds and methods of use
granted
Frequently asked questions
What is ergocalciferol?
ergocalciferol (ERGOCALCIFEROL) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ergocalciferol?
ERGOCALCIFEROL is a marketed brand name for ergocalciferol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ergocalciferol?
ergocalciferol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.